Riskpilot← Back to searchSign inGet full accessRonneby Veterinärklinik AB
ABActiveOrg 5568459019Rosengatan 15Veterinary activities · NACE 7500Est. 20119 employees
Revenue 2024
SEK 11,8M
-14% vs 2023
EBITDA margin
22.9%
-26% vs 2023
Equity ratio
35.6%
Financial strength
Net profit 2024
SEK 1,2M
-58% vs 2023
| Revenue | SEK 11,8M | -14% |
| EBITDA | SEK 2,7M | -26% |
| Net profit | SEK 1,2M | -58% |
| Total assets | SEK 8,5M | -5% |
| Equity | SEK 3M | +0% |
| Employees | 9 | — |
Legal name
Ronneby Veterinärklinik AB
Org number
5568459019
Legal form
Aktiebolag
NACE code
7500 · Veterinary activities
Founded
14 mars 2011
Share capital
SEK 50 000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva veterinärklinik, programutveckling till veterinärbranschen, fastighetsförvaltning samt därmed förenlig verksamhet.
Address
Rosengatan 15
Phone
+46703266084
Email
info@ronnebyvet.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 9 471 | 10 355 | 11 659 | 13 711 | 11 772 |
| Staff expenses | — | — | — | — | −5 126 |
| EBITDA | 2 556 | 2 569 | 1 061 | 3 631 | 2 694 |
| Depreciation & amort. | −364 | −397 | −465 | −456 | −431 |
| EBIT | 2 192 | 2 172 | 596 | 3 175 | 2 264 |
| Net financials | −94 | −90 | −81 | −77 | −77 |
| Profit before tax | 1 621 | 1 465 | 2 145 | 3 716 | 1 600 |
| Tax | −355 | −310 | −429 | −770 | −359 |
| Net profit | 1 266 | 1 155 | 1 716 | 2 946 | 1 241 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 9 294 | 10 246 | 9 412 | 8 897 | 8 459 |
| Equity | 2 863 | 2 268 | 3 296 | 3 018 | 3 009 |
| Long-term debt | 3 606 | 3 803 | 3 705 | 3 608 | 3 510 |
| Short-term debt | 1 195 | 1 927 | 1 793 | 2 272 | 1 353 |
| Total debt | 4 801 | 5 730 | 5 498 | 5 880 | 4 863 |
EBITDA margin
22.9%
This company
15.8%
Market median
+45% vs market
20202024
Equity ratio
35.6%
This company
38.2%
Market median
+7% vs market
20202024
Return on equity
41.2%
This company
18.4%
Market median
+124% vs market
20202024
Net profit margin
10.5%
This company
8.1%
Market median
+30% vs market
20202024
Asset turnover
1.39×
This company
1.12×
Market median
+24% vs market
20202024
Debt / equity
1.81×
This company
0.62×
Market median
-192% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KM | Audit | 2022 |
EC Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
LZ Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2023 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ronneby Veterinärklinik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjell Markus Andersson | Audit | 0 companies |
| László Zoltán Tóth | Chief Executive Officer | 0 companies |
| Emma Caroline Marianne Swedenås | Chief Executive Officer | 0 companies |
| Simon Myrén | Deputy Board Member | 0 companies |
| Annika Margareta Green | Deputy Board Member | 0 companies |